These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14621284)

  • 1. Predictive value of complement activation fragments C3a and sC5b-9 for development of severe disease in patients with acute pancreatitis.
    Gloor B; Stahel PF; Müller CA; Schmidt OI; Büchler MW; Uhl W
    Scand J Gastroenterol; 2003 Oct; 38(10):1078-82. PubMed ID: 14621284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients.
    Chiu YY; Nisihara RM; Würzner R; Kirschfink M; de Messias-Reason IJ
    J Investig Allergol Clin Immunol; 1998; 8(4):239-44. PubMed ID: 9777539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of pleural complement activation products in differentiating tuberculosis and malignant effusions.
    Porcel JM; Vives M; Gázquez I; Vicente de Vera MC; Pérez B; Rubio M
    Int J Tuberc Lung Dis; 2000 Jan; 4(1):76-82. PubMed ID: 10654648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleural SC5b-9: a test for identifying complicated parapneumonic effusions.
    Vives M; Porcel JM; Gázquez I; Pérez B; Rubio M
    Respiration; 2000; 67(4):433-8. PubMed ID: 10940799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylatoxins and terminal complement complexes in pancreatitis. Evidence of complement activation in plasma and ascites fluid of patients with acute pancreatitis.
    Roxvall LI; Bengtson LA; Heideman JM
    Arch Surg; 1990 Jul; 125(7):918-21. PubMed ID: 2369318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylatoxin generation in acute pancreatitis.
    Roxvall L; Bengtson A; Heideman M
    J Surg Res; 1989 Aug; 47(2):138-43. PubMed ID: 2787873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in plasma complement levels after human ischemic stroke.
    Mocco J; Wilson DA; Komotar RJ; Sughrue ME; Coates K; Sacco RL; Elkind MS; Connolly ES
    Neurosurgery; 2006 Jul; 59(1):28-33; discussion 28-33. PubMed ID: 16823297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation products in acute heart failure: Potential role in pathophysiology, responses to treatment and impacts on long-term survival.
    Trendelenburg M; Stallone F; Pershyna K; Eisenhut T; Twerenbold R; Wildi K; Dubler D; Schirmbeck L; Puelacher C; Rubini Gimenez M; Sabti Z; Osswald L; Breidthardt T; Müller C
    Eur Heart J Acute Cardiovasc Care; 2018 Jun; 7(4):348-357. PubMed ID: 29064269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic activation of the complement system in patients with advanced age-related macular degeneration.
    Lynch AM; Mandava N; Patnaik JL; Frazer-Abel AA; Wagner BD; Palestine AG; Mathias MT; Siringo FS; Cathcart JN; Holers VM
    Eur J Ophthalmol; 2020 Sep; 30(5):1061-1068. PubMed ID: 31203676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma levels of soluble tumor necrosis factor receptor (sTNFRp60) reflect severity of acute pancreatitis.
    Kaufmann P; Tilz GP; Lueger A; Demel U
    Intensive Care Med; 1997 Aug; 23(8):841-8. PubMed ID: 9310801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complement activation products (C3a and C5b-9) as markers of activity of dermatomyositis. Comparison with usual biochemical parameters].
    Campo A; Hausmann G; Martí RM; Estrach T; Grau JM; Porcel JM; Herrero C
    Actas Dermosifiliogr; 2007; 98(6):403-14. PubMed ID: 17663930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of C3a is Associated with Hemorrhagic Propensity in Patients with Immune Thrombocytopenia.
    Ge J; Wang L; Li J; Hu Y; Xu Q; Chen Y; Hou R; Ruan M; Xia R; Zeng Q
    Clin Lab; 2017 Apr; 63(4):765-771. PubMed ID: 28397467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White blood cell counts and plasma C3a have synergistic predictive value in patients at risk for acute respiratory distress syndrome.
    Gama de Abreu M; Kirschfink M; Quintel M; Albrecht DM
    Crit Care Med; 1998 Jun; 26(6):1040-8. PubMed ID: 9635653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
    Iatrou C; Afentakis N; Nomikos T; Dinas C; Stavropoulos-Giokas C; Antonopoulou S
    Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
    Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
    Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator.
    Agostoni A; Gardinali M; Frangi D; Cafaro C; Conciato L; Sponzilli C; Salvioni A; Cugno M; Cicardi M
    Circulation; 1994 Dec; 90(6):2666-70. PubMed ID: 7994806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between complement system's activation factors and anti-angiogenesis factors in plasma of patients with early/late-onset severe preeclampsia.
    He Y; Xu B; Song D; Yu F; Chen Q; Zhao M
    Hypertens Pregnancy; 2016 Nov; 35(4):499-509. PubMed ID: 27315511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte tissue factor expression and ongoing complement generation in ventricular assist device patients.
    Wilhelm CR; Ristich J; Kormos RL; Wagner WR
    Ann Thorac Surg; 1998 Apr; 65(4):1071-6. PubMed ID: 9564930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement Components sC5b-9 and CH50 Predict Prognosis in Heart Failure Patients Combined With Hypertension.
    Wang W; Cai D
    Am J Hypertens; 2020 Jan; 33(1):53-60. PubMed ID: 31429866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong complement activation after acute ischemic stroke is associated with unfavorable outcomes.
    Széplaki G; Szegedi R; Hirschberg K; Gombos T; Varga L; Karádi I; Entz L; Széplaki Z; Garred P; Prohászka Z; Füst G
    Atherosclerosis; 2009 May; 204(1):315-20. PubMed ID: 18804761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.